Table VII.
Treatment decisions before and after 21-gene RS test.
| Treatment decisions | Low RS n=62, n (%) | Intermediate RS n=4, n (%) | High RS n=7, n (%) | Total n=110, n (%) |
|---|---|---|---|---|
| No C recommended before RS | 34 (55) | 14 (34) | 1 (14) | 49 (45) |
| No C recommended after RS | 34 (55) | 14 (34) | 0 (0) | 48 (44) |
| C recommended after RS | 0 (0) | 0 (0) | 1 (14) | 1 (1) |
| C recommended before RS | 28 (45) | 27 (66) | 6 (86) | 61 (55) |
| C recommended after RS | 4 (6) | 19 (46) | 6 (86) | 29 (26) |
| No C recommended after RS | 24 (39) | 8 (20) | 0 (0) | 32 (29) |
| Overall change | 24 (39) | 8 (20) | 1 (14) | 33 (30) |
C, chemotherapy; RS, recurrence score.